当前位置: 首页 > 详情页

Activation of protein kinase C epsilon enhanced movement ability and paracrine function of rat bone marrow mesenchymal stem cells partly at least independent of SDF-1/CXCR4 axis and PI3K/AKT pathway

| 认领 | 导出 |

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Capital Med Univ, Beijing Anzhen Hosp, Dept Emergency Cardiol, Beijing 100029, Peoples R China; [2]Pudong New Area Dist Zhoupu Hosp, Dept Cardiol, Shanghai 201318, Peoples R China; [3]Capital Med Univ, Beijing Anzhen Hosp, Dept Emergency Cardiol, Anzhen Rd Second, Beijing 100029, Peoples R China
出处:
ISSN:

关键词: PKC epsilon stem cells migration paracrine factors

摘要:
Objects: to probe into the effects of PKC epsilon on migration and paracrine functions of stem cells and potential molecular mechanisms. Methods: Bone Marrow mesenchymal stem cells (BMMSCs) were obtained from rat femur and passaged. mRNA and protein levels of capital proteins in PKC epsilon signaling, SDF-1/CXCR4 axis and PI3K/AKT pathway in the MSCs in different conditions treating with PKC agonist, specific PKC epsilon inhibitor, CXCR4 antagonist or PI3K inhibitor for 24 hours were analyzed by real-time PCR and western blot, and migration abilities were observed by migration assay in vitro and the changes of paracrine factors in different treatments were analyzed by protein clips assay. Results: the levels of p-JNK, p-P38MAPK, SDF-1, CXCR4, PI3K and p-AKT increased significantly after treating with PKC agonist (P < 0.05) and decreased obviously after treating with specific PKC epsilon inhibitor. Migration ability and paracrine function of MSCs were enhanced in PMA group and attenuated in PKC epsilon inhibitor group, and inhibiting activity of CXCR4 or PI3K attenuated the effects of PKC epsilon, but not abolished completely. Conclusion: There was cross-talking between PKC epsilon signaling and SDF-1/CXCR4 axis and PI3K/AKT pathway in signal transduction of MSCs. Activating PKC epsilon could improve migration ability and paracrine function of MSCs partly at least independent of SDF-1/CXCR4 axis and PI3K/AKT pathway.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2014]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验
最新[2023]版:
JCR分区:
出版当年[2013]版:
Q3 MEDICINE, RESEARCH & EXPERIMENTAL
最新[2023]版:
Q4 MEDICINE, RESEARCH & EXPERIMENTAL

影响因子: 最新[2023版] 最新五年平均 出版当年[2013版] 出版当年五年平均 出版前一年[2012版] 出版后一年[2014版]

第一作者:
第一作者机构: [1]Capital Med Univ, Beijing Anzhen Hosp, Dept Emergency Cardiol, Beijing 100029, Peoples R China;
通讯作者:
通讯机构: [1]Capital Med Univ, Beijing Anzhen Hosp, Dept Emergency Cardiol, Beijing 100029, Peoples R China; [3]Capital Med Univ, Beijing Anzhen Hosp, Dept Emergency Cardiol, Anzhen Rd Second, Beijing 100029, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院